Parmar Kush
- Assets, Funds, Holdings
| Parmar Kush
|
| CIK # | 0001664281 |
| Form 3/4/5 Subject |
2011 - 2025 |
|
Entrada Therapeutics, Inc.
|
|
|
Parmar Kush
|
|
|
Camp4 Therapeutics Corp
|
|
|
5AM Opportunities II, L.P.
|
|
|
5AM Partners VI, LLC
|
|
|
5AM Ventures VI, L.P.
|
|
|
5AM Opportunities II (GP), LLC
|
|
|
5AM Co-Investors II LP
|
|
|
5AM Partners VII, LLC
|
|
|
Skye Bioscience, Inc.
|
|
|
5AM Ventures VII, L.P.
|
|
|
5AM Ventures II LP
|
|
|
Rocklage Scott M
|
|
|
5AM Partners II, LLC
|
|
|
Diekman John D
|
|
|
Artiva Biotherapeutics, Inc.
|
|
|
Schwab Andrew J.
|
|
|
Rallybio Corp
|
|
|
5AM Opportunities I, L.P.
|
|
|
5AM Opportunities I (GP), LLC
|
|
|
Enliven Therapeutics, Inc.
|
|
|
CinCor Pharma, Inc.
|
|
|
Akouos, Inc.
|
|
|
Q32 Bio Inc.
|
|
|
Vor Biopharma Inc.
|
|
|
5AM Partners V, LLC
|
|
|
Cabaletta Bio, Inc.
|
|
|
5AM Ventures V, L.P.
|
|
|
IPI Legacy Liquidation Co
|
|
|
5:01 Acquisition Corp.
|
|
|
5AM Ventures IV, L.P.
|
|
|
5AM Co-Investors IV, L.P.
|
|
|
Aprea Therapeutics, Inc.
|
|
|
5AM Partners IV, LLC
|
|
|
Arvinas Inc
|
|
|
scPharmaceuticals Inc.
|
|
|
Audentes Therapeutics, Inc.
|
|
{"search": "/search", "clicked": "/clicked", "portfolio_add": "/portfolio-add", "portfolio_remove": "/portfolio-remove", "portfolio_create": "/portfolio-create", "portfolio_activate": "/portfolio-activate", "portfolio_delete": "/portfolio-delete", "portfolio_rename": "/portfolio-rename", "portfolio_color": "/portfolio-color", "home_filter": "/home-filter", "htmlspeed": "/htmlspeed", "add_tag_firm": "/add-tag-firm", "add_tag_click": "/add-tag-click", "copy_aum": "/copy-aum", "stripe_checkout": "/stripe-checkout", "update_card": "/update-card"}
{"uid": 170712070, "pid": -1, "pid_a": [], "name": "", "email": "", "blacklist_f": false, "paywall_f": false, "paywall_n": 0, "random_n": 0}
False
250386750